Centene Corporation

CNC Healthcare Healthcare Plans

Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.92%, EPS grew 533.3%, free cash flow grew 116.6% and total debt fell 8.37%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.

68.86 1.84 +2.75%
Market cap
$33.1B
P/E
0.0×
Fwd P/E
24.8×
Dividend yield
—
F-score
5/9
Altman Z
2.64
Beneish M
−3.07
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 9.66 15.58 38.34 35.67 19.24 19.71 24.32 21.38 18.06
Piotroski F-Score
5 5 8 7 5 5 5 5 4 4
Altman Z-Score
2.64 2.76 2.60 2.67 2.43 2.41 2.90 2.95 3.23 2.71
P/S ratio
0.10 0.19 0.27 0.32 0.38 0.31 0.35 0.37 0.37 0.23
P/FCF ratio
4.70 0.00 5.75 8.72 14.58 7.39 34.52 40.25 16.58 6.02
Altman Z″-Score (non-manufacturers)
0.39 1.66 1.47 1.14 1.27 1.43 2.34 1.29 1.07 1.08
Beneish M-Score
(3.07) (1.99) (2.70) (2.79) (2.31) (2.16) (2.29) (2.18) (2.47) (1.70)
P/Operating CF
46.43 (53.85) 192.37 (29.10) 71.15 11.49 (39.93) (35.49) 39.31 5.85
P/B ratio
1.01 1.19 1.61 1.90 1.78 1.32 2.05 2.04 2.58 1.57
Price to Tangible BV
4.35 8.95 18.32 0.00 0.00 0.00 6.96 12.79 24.67 0.00
EV/Sales
0.09 0.21 0.26 0.34 0.41 0.35 0.36 0.38 0.37 0.23
EV/EBITDA
0.00 7.58 9.45 18.01 16.74 8.91 11.03 11.84 11.40 6.18
EV/Operating CF
3.41 217.26 4.96 7.90 12.42 7.03 18.03 18.74 11.95 5.15
EV/FCF
4.02 (68.28) 5.50 9.41 15.84 8.34 35.51 41.36 16.67 6.17
Quick Ratio
1.05 1.06 0.96 0.97 1.04 1.02 1.49 0.94 0.86 0.89
Current Ratio
1.10 1.11 1.11 1.06 1.11 1.08 1.57 1.00 0.93 0.97
Net Debt/EBITDA
0.46 0.42 (0.43) 1.32 1.34 1.01 0.31 0.32 0.06 0.14
Debt/Assets
22.67% 22.48% 21.06% 23.44% 24.04% 24.42% 33.48% 21.64% 21.50% 23.05%
Debt/Equity
0.87 0.70 0.69 0.75 0.70 0.65 1.08 0.61 0.68 0.79
Asset Turnover
2.45 1.95 1.91 1.86 1.71 2.03 2.08 2.28 2.30 2.95
Operating CF/Net income
(0.76) 0.05 2.98 5.21 3.12 3.04 1.12 1.37 1.80 3.29
Capex/Depreciation
(0.60) (0.52) (0.62) (0.70) (0.68) (0.69) (1.14) (1.36) (1.17) (1.10)
Interest Coverage
(11.24) 4.52 4.04 1.98 2.68 4.23 4.32 4.25 4.70 5.82
ROE
(28.69%) 12.61% 10.78% 4.70% 5.10% 9.38% 11.16% 10.07% 12.96% 13.92%
ROA
(8.38%) 3.96% 3.35% 1.55% 1.83% 3.30% 3.67% 3.41% 3.94% 4.08%
ROIC
(27.84%) 7.00% 7.59% 2.96% 3.58% 6.36% 8.31% 7.83% 10.77% 12.88%
Return on Tangible Assets
(116.86%) 56.93% 44.59% 29.35% 22.00% 39.46% 13.89% 51.93% 174.32% 104.27%
Average Days of Receivables
33.93 44.12 36.81 33.51 35.46 31.85 30.55 31.27 25.75 28.90
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
6.63% 7.60% 8.16% 8.02% 7.62% 8.44% 8.75% 10.05% 9.19% 9.05%
Intangible Assets out of Total Assets
0.20 0.28 0.28 0.33 0.35 0.39 0.22 0.30 0.28 0.31
Share Based Compensation of Revenue
0.10% 0.13% 0.14% 0.16% 0.16% 0.25% 0.24% 0.24% 0.28% 0.36%
Graham Net Nets
(0.81) (0.57) (0.43) (0.49) (0.48) (0.57) (0.31) (0.35) (0.36) (0.64)
Graham Number
0.00 84.64 72.77 44.36 49.01 56.43 46.88 38.79 32.78 25.94
Earnings Yield
(33.07%) 10.35% 6.42% 2.61% 2.80% 5.20% 5.07% 4.11% 4.68% 5.54%
Free Cash Flow Yield
21.29% (1.55%) 17.38% 11.46% 6.86% 13.53% 2.90% 2.48% 6.03% 16.60%
Revenue per Share
394.99 312.52 283.44 251.30 216.15 194.69 180.51 154.05 140.30 127.24
Operating CF per Share
10.32 0.30 14.82 10.89 7.21 9.64 3.59 3.16 4.32 5.80
Capex per Share
(1.56) (1.23) (1.47) (1.75) (1.56) (1.52) (1.77) (1.73) (1.22) (0.96)
Free Cash Flow per Share
8.76 (0.94) 13.35 9.14 5.65 8.12 1.82 1.43 3.09 4.84
Cash per Share
41.21 31.98 36.17 25.03 25.15 21.69 31.41 15.54 13.35 13.90
Shareholders Equity per Share
40.63 50.79 47.74 42.04 46.22 45.35 30.62 28.22 19.90 18.52
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
40.63 50.79 47.74 42.04 46.22 45.35 30.62 28.22 19.90 18.52
Free Cash Flow
4,321.00 (490.00) 7,254.00 5,257.00 3,295.00 4,634.00 753.00 559.00 1,067.00 1,545.00
Working Capital
3,674.00 3,738.00 4,040.00 1,664.00 2,732.00 1,808.00 7,391.00 27.00 (629.00) (258.00)
Capital Expenditures
(767.00) (644.00) (799.00) (1,004.00) (910.00) (869.00) (730.00) (675.00) (422.00) (306.00)
Net Current Asset Value
(16,344.00) (17,946.00) (17,948.00) (22,561.00) (22,938.00) (19,441.00) (8,012.00) (7,890.00) (6,288.00) (5,923.00)
EV/EBIT
0.00 10.54 13.62 37.55 29.26 12.54 15.01 15.86 14.83 7.54
Capex to Sales
0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Price to Operating Income
0.00 9.96 14.25 34.80 26.92 11.12 14.60 15.43 14.75 7.37
Other line items
Depreciation/Fixed assets
0.63 0.60 0.64 0.59 0.39 0.45 0.30 0.29 0.33 0.35
Cash ROIC
7.48% (0.79%) 11.44% 9.29% 5.45% 8.42% 1.91% 2.35% 6.60% 10.30%
Accounts Receivable Turnover
10.30 9.25 10.69 11.33 11.49 13.94 13.10 14.04 14.60 18.07
Accounts Payable Turnover
13.43 9.88 10.54 14.20 14.37 17.07 16.02 12.58 10.74 14.80
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
27.79 32.88 43.85 27.18 27.73 26.91 23.10 28.60 35.70 39.17
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
18,909.00 17,622.50 14,402.00 12,755.00 10,967.00 7,971.50 5,698.50 4,281.50 3,314.00 2,247.00
Average Payables
13,474.00 14,797.00 12,972.50 9,009.00 7,781.00 5,616.50 4,107.50 4,108.00 3,964.00 2,369.50
Average Assets
79,596.00 83,543.00 80,755.50 77,622.50 73,547.00 54,856.50 35,947.50 26,378.00 21,026.00 13,768.00
Average Common Equity
23,266.50 26,218.50 25,059.00 25,560.50 26,412.50 19,272.00 11,836.00 8,938.50 6,386.50 4,038.50

Fold the line items

Columns are period end dates